Raymond James Financial Inc. Invests $11.57 Million in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Raymond James Financial Inc. acquired a new position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 1,563,296 shares of the biotechnology company’s stock, valued at approximately $11,568,000. Other institutional investors and hedge funds have also recently modified their holdings of the company. SBI Securities Co. Ltd. […]
Raymond James Financial Inc. acquired a new position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the fourth quarter, HoldingsChannel.com reports. The fund acquired 1,563,296 shares of the biotechnology company’s stock, valued at approximately $11,568,000. Other institutional investors and hedge funds have also recently modified their holdings of the company. SBI Securities Co. Ltd. […]
